Similarly as with NF-κB1, we also did not observe a difference between the NF-κB2 concentration in brain tumor patients who died compared to brain tumor patients who survived the following 2 years (p = 0.1148) (Figs 2 and 4). This evidence concerns the gene NFKB1 and brain neoplasm.